Penserra Capital Management LLC Qiagen N.V. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$39.13 - $47.24 $391 - $472	10 Added 2.67%	384 $15,000
Q2 2023 Aug 11, 2023	BUY	$43.93 - $46.76 $1,054 - $1,122	24 Added 6.86%	374 $16,000
Q1 2023 Apr 24, 2023	BUY	$45.29 - $50.76 $452 - $507	10 Added 2.94%	350 $16,000
Q4 2022 Feb 13, 2023	SELL	$41.91 - $50.48 $58,422 - $70,369	-1,394 Reduced 80.39%	340 $16,000
Q3 2022 Nov 14, 2022	BUY	$40.9 - $50.42 $57,832 - $71,293	1,414 Added 441.88%	1,734 $71,000
Q1 2022 May 13, 2022	BUY	$42.23 - $54.3 $13,513 - $17,376	320 New	320 $15,000

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.2B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.